Novel antimicrobial antibiotics against Pasteurella piscicida, tetrodecamycin (1) and weakly active dihydrotetrodecamycin (2) were isolated from a culture broth of Streptomyces nashvillensis MJ885-mF8.The planar structure of 1 was determined to be 2-acyl-4-ylidene tetronic acid alkyl ether containing decaline ring by various NMRspectral data of 1 and its acetyl derivative (3). The structure of 2 was elucidated by comparison with the spectral data of 1 and confirmed by catalytic reduction of 1 into 2. The X-ray crystallography of 2 showed the relative stereochemistry. Their absolute configurations were determined by using modified Mosher's method.
Pseudotuberculosis caused by Pasteurella piscicida is one of the most widely distributed bacterial diseases of cultured yellowtail, Seriola quinqueradiata.^Prevention of this disease is therefore considered as an important aspect for the successful culture of yellowtail. During our screening program on this aspect, we have isolated new antibiotics, tetrodecamycin (1) and dihydrotetrodecamycin (2) from a culture broth of Streptomyces nashvillensis MJ885-mF8.In the preceding paper2), we have described the taxonomy, fermentation, isolation, characterization and biological activities of 1 and 2. In this paper, we describe details of the structural elucidation of 1 and 2.
Results
The physico-chemical properties of tetrodecamycin (1) Fig. 1. The structures of tetrodecamycin (1), dihydrotetrodecamycin (2) and acetyl derivative (3).
and dihydrotetrodecamycin (2) were described in the previous paper2). The color reactions of 1 and 2 were positive to iodine and molybdophosphoric acid-sulfuric acid reagent and negative to FeCl3, ninhydrin and
Rydon-Smith reagents. The UV spectra of 1 and 2 in
MeOH showeda characteristic absorption maximum at 271 nmand 249nm, respectively. The IR spectrum of 1 suggested the presence of hydroxyl group (3460cm" 1) and y-lactone (1780cm"1) and the similar value of 2 (3530 and 1760 cm" 1) suggested the presence of the same functional groups as 1.
Structure of Tetrodecamycin
The molecular formula of tetrodecamycin (1) was determined to be C18H22O6 on the basis ofHRFAB-MS data. This molecular formula was supported by XH and 13C NMR spectral data of 1 (Table 1) . The 13C NMR spectral data of 1 showed 17 signals but two signals overlapped at 164.64ppm. All one bond connections between XHand 13C were interpreted by DEPTand heteronuclear multiple quantum coherence (HMQC)3) experiments of 1 (Table 1) . Two partial structures in Fig. 2 were substantiated by interpretation of the^^H COSYspectrum. The XH-13C long range coupling in the heteronuclear multiple bond correlation (HMBC)4) experiment of 1 connected two partial structures and fixed positions of three sub- Chemical shifts in ppm from TMSas an internal standard. * It is overlapped by H2O. stituents; a tertiary hydroxyl group (13-OH), a methyl group (17-CH3) and a carbonyl group (C-6). These data established a substituted decaline residue. The presence of an exo-methylene group (SH 5.36 and 5.26) was also indicated by the HMBCspectrum.
The remaining chromophore part consisting of a carbonyl group, the exo-methylene group (above mentioned), a fully substituted olefine group (C-2 (<5C 100.79) and C-3 (Sc 164.64)) and an ester group (C-l, dc 164.64) could not be assigned a structure due to the overlapping signals of C-l and C-3 at 164.64ppm. explained by the existence of an acyl tetronic acid alkyl ether structure as seen in gregatin B5) (Fig. 4 ). This result was further supported by the IR spectrum (y-lactone;
1780cm"1)6) and the UV spectrum (2-acyl-4-ylidene tetronic acid alkyl ether; 271 nm)7). From these data, the planar structure of tetrodecamycin was established.
Structure of Dihydrotetrodecamycin The molecular formula of dihydrotetrodecamycin (2) was determined to be C18H24O6 on the basis of HRFAB-MSdata and was supported by the^H and 13C NMRspectral data (Table 1) . The XH and 13C NMR data of2 were similar to those of 1 but the signals arising from the exo-methylene part were lacking. Instead of the exo-methylene group, one methyl and one methine group were observed in the *H and 13C NMRspectrum of 2. Additionally, a shift to shorter wave length (249 nm) of the UVabsorption maximumof 2 compared with the value (271 nm) of 1 suggested partial reduction of the chromophore part. From these spectroscopic data, the structure of 2 was deduced to be 4,5-dihydrotetrodecamycin.
Relative Stereochemistry Among tetrodecamycin
(1), dihydrotetrodecamycin
(2) and 14-O-acetyl-tetrodecamycin (3), 2 was recrystallized from a CHC13solution to give colorless prismatic crystals. A crystal which had approximate dimensions of 0.22 x 0.30 x 0.35mm was chosen for the X-ray analysis and the stereochemistry was studied. As a result, the relative stereochemistry of 2 was determined. The ORTEP drawing of2 was shown in Fig. 5 .8) Crystal data were summerized in Table 2 .
The relative stereochemistry of 1 was proved by conversion of 1 into 2. The compound 1 was hydrogenated in the presence of 10% palladium-carbon in EtOHto give two epimers, which were separated by HPLC (YMC-Pack, ODS-A, 150 x 4.6mm) using 30% aqueous MeOH.The 1H NMRdata and specific rotation of one epimer were the same as those of 2. Therefore, The thermal ellipsoids were given at 50% probability. Fig. 6 , the configuration of C-14 was concluded to be R: Therefore, the absolute structure was established to be 7R, SS, 13S, HR, 15S and 16Sfor 1 andAR, 7R, 8S, US, UR, 15Sand 165 for2.
Experimental

General
UVabsorption spectra were measured with a Hitachi U-3210 spectrophotometer. IR absorption spectra were obtained with a Hitachi 1-5020 FT-IR and Hitachi 260-30 spectrometer. FAB-MSand HRFAB-MS were obtained on a JEOL JMS-SX102 mass spectrometer. XHand 13C NMRspectra were recorded on a JEOLJNM-GX400 and JNM-A-500 spectrometer. Chemical shift is given in ppm using TMSas an internal standard. Optical rotations were taken by a Perkin-Elmer 241 polarimeter using a micro-cell (light path 10cm).
Preparation of 14-Acetyltetrodecamycm (3) Acetic anhydride (2ml) was poured into a solution of tetrodecamycin (1) (30.5mg, 0.091 mmol) in pyridine (2ml) at 0°C. The reaction mixture was stirred at room temperature for 18 hours. After evaporation under reduced pressure, the residue was purified by preparative TLC (Merck, Kiesel gel 60F254) using toluene-acetone (2 : 1)mixture to give3 (31.6mg, 92%) aswhitepowder.
The XH and 13C NMRdata were showed in Table 1 
X-Ray Crystallography
The crystal of 2 was recrystallized from a CHC13 solution. A colorless prism crystal having approximate dimensions of 0.22 x 0.30 x 0.35mmwas mounted on a glass fiber. All measurements were made on a Rigaku AFC7Rdiffractometer with graphite monochromated Cu-Ka radiation and a rotating anode generator. Crystal data are shown in Table 2 . Of the 3490 reflections which were collected, 1903 were unique. No decay correction was applied. Anempirical absorption correction using the program DIFABS10) was applied which resulted in transmission factors ranging from 0.38 to 1.77. The structure was solved by direct method (SHELXS8611}) and expanded using Fourier techniques (DIRDIF9212)).
The non-hydrogen atoms were refined anisotropically.
Hydrogen atoms were included but not refined. 82.4, 69.1, 55.6, 52.8, 42.9, 38.8, 33.8, 25.7, 23.1, 20.3, 17.4, 13.1. 
